Candela Sees Beaming Future In Family Practice As Stock Jumps 54%
This article was originally published in The Gray Sheet
Executive Summary
Candela's improved access to the emerging family practice aesthetic market through an exclusive distribution deal with McKesson sparked investor interest in the aesthetic laser firm in November
You may also be interested in...
Inamed To Spurn Medicis? Aesthetics Firm Weighs Allergan’s $3.2 Bil. Offer
Inamed is considering a $3.2 bil. unsolicited offer from pharmaceutical specialty firm Allergan after determining that the bid is likely superior to its planned merger with Medicis, the firm announced Nov. 16
St. Jude Offers $1.3 Bil. For ANS, Citing Low-Voltage Technology Synergy
St. Jude Medical cites technological synergies and near-term revenue growth as justification for its offer to acquire Advanced Neuromodulation Systems for $1.3 bil
Possis Aims To Reverse AngioJet Losses With JETSTENT Trial
Possis views its upcoming 500-patient JETSTENT trial as the final step in a three-part plan to overcome the damaging results of its 2004 AiMI study and recover lostAngioJet thrombectomy system sales